DUBLIN (BUSINESS WIRE) The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining.
/PRNewswire/ The "Long-Acting Injectable Drugs" report has been added to ResearchAndMarkets.com s offering. Chronic conditions require drug administration.